|
1.
|
原著(症例報告除く)
|
先天性無フィブリノゲン血症に併発した十二指腸潰瘍と腹膜穿孔の1例 2025/10
|
|
2.
|
原著(症例報告除く)
|
Efficacy of initial combination therapy with anti-SARS-CoV-2 antivirals targeting viral clearance in COVID-19 patients with B-cell lymphoma treated with anti-CD20 antibodies: A retrospective single-centre study in Japan. 2025/07
|
|
3.
|
原著(症例報告除く)
|
重篤な出血症状で救急搬送された後天性血友病Aの1例 2024/12
|
|
4.
|
原著(症例報告除く)
|
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody 2024/07
|
|
5.
|
症例報告
|
Successful treatment of Dara sc-CyBorD in a patient with AL amiyloidosis and severe heart failure 2024/04
|
|
6.
|
原著(症例報告除く)
|
自己免疫性後天性凝固第IX因子欠乏症(後天性血友病B)の1例 2023/12
|
|
7.
|
原著(症例報告除く)
|
成人になって初めて診断がついた先天性血友病AのPUPs例 2023/12
|
|
8.
|
原著(症例報告除く)
|
【胸部の最新画像情報 2023】緩徐な増大傾向を認めた肺アミロイドーシスの2例 2023/01
|
|
9.
|
原著(症例報告除く)
|
Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation 2023
|
|
10.
|
原著(症例報告除く)
|
下腿浸潤を呈した鼻腔原発びまん性大細胞型B細胞性リンパ腫の1例 2022/12
|
|
11.
|
原著(症例報告除く)
|
Real-world efficacy of letermovir prophylaxis for cytomegaloviru infections after allogeneic hematopoietic stem cell transplantations: A single-center retrospective analysis 2022/09
|
|
12.
|
原著(症例報告除く)
|
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation 2021/08
|
|
13.
|
その他
|
What's your diagnosis?(第218回) 拍手、拍手、拍手 2021/02
|
|
14.
|
原著(症例報告除く)
|
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis 2020/12
|
|
15.
|
原著(症例報告除く)
|
Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan. 2020/11
|
|
16.
|
原著(症例報告除く)
|
Comparison of Starting Doses of Anagrelide as a First-Line Therapy in Patients With Cytoreductive Therapy-Naïve Essential Thrombocythemia: Difference Between Starting at 0.5 and 1.0 Mg/Day 2020/07
|
|
17.
|
原著(症例報告除く)
|
Primary dural high grade B cell lymphoma mimicking subdural hematoma 2020/03
|
|
18.
|
原著(症例報告除く)
|
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting. 2020/02
|
|
19.
|
症例報告
|
Primary dural high grade B cell lymphoma mimicking subdural hematoma. 2020
|
|
20.
|
原著(症例報告除く)
|
Effect of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation 2019/12
|
|
21.
|
原著(症例報告除く)
|
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation. 2019/12
|
|
22.
|
症例報告
|
Intravascular Large B-Cell Lymphoma; Our Experience with the Disease at Two Medical Centers 2019/12
|
|
23.
|
原著(症例報告除く)
|
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era. 2019/12
|
|
24.
|
症例報告
|
Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis. 2019/11
|
|
25.
|
症例報告
|
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms. 2019/09
|
|
26.
|
原著(症例報告除く)
|
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma. 2019/08
|
|
27.
|
原著(症例報告除く)
|
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting. 2019/08
|
|
28.
|
その他
|
Efficacy of CMV prophylaxis with letermovir early after transplantation. 2019/07
|
|
29.
|
原著(症例報告除く)
|
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma. 2019/05
|
|
30.
|
原著(症例報告除く)
|
Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan. 2019/05
|
|
31.
|
原著(症例報告除く)
|
Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation. 2019/04
|
|
32.
|
原著(症例報告除く)
|
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience. 2019/03
|
|
33.
|
症例報告
|
Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia. 2019/03
|
|
34.
|
原著(症例報告除く)
|
Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β1, and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia. 2018/12
|
|
35.
|
原著(症例報告除く)
|
Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia. 2018/09
|
|
36.
|
原著(症例報告除く)
|
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study. 2018/08
|
|
37.
|
その他
|
自家末梢血幹細胞移植後のbrentuximab vedotin維持療法が奏効した高リスクHodgkinリンパ腫 2018/08
|
|
38.
|
原著(症例報告除く)
|
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide. 2018/07
|
|
39.
|
原著(症例報告除く)
|
Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia. 2018/05
|
|
40.
|
原著(症例報告除く)
|
Human T-cell Leukemia Virus Type I Associated with an Increased Risk of Primary Malignant Neoplasm. 2018/04
|
|
41.
|
症例報告
|
Beneficial Effect of Bendamustine in a Patient with Anti-MAG/SGPG Neuropathy and Bing-Neel Syndrome Associated with Waldenström Macroglobulinemia: A Case Report. 2018/03
|
|
42.
|
原著(症例報告除く)
|
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma. 2018/01
|
|
43.
|
原著(症例報告除く)
|
How to select Tyrosine Kinase Inhibitor for the patients with newly diagnosed Chronic Myeloid Leukemia? 2018
|
|
44.
|
症例報告
|
Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma 2018
|
|
45.
|
症例報告
|
Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection. 2017/12
|
|
46.
|
原著(症例報告除く)
|
胃癌を合併しATRAでコントロール良好となったAPL再発の一例 2017/12
|
|
47.
|
原著(症例報告除く)
|
腰部脊柱管狭窄症の手術を実施したITP症例 2017/12
|
|
48.
|
症例報告
|
Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents. 2017/10
|
|
49.
|
原著(症例報告除く)
|
Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions 2017/09
|
|
50.
|
原著(症例報告除く)
|
Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma 2017/09
|
|
51.
|
原著(症例報告除く)
|
Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation 2017/08
|
|
52.
|
原著(症例報告除く)
|
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience 2017/07
|
|
53.
|
その他
|
代表的血液悪性腫瘍について-見逃すと大変なことになる血液疾患- 2017/04
|
|
54.
|
原著(症例報告除く)
|
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era 2017/02
|
|
55.
|
原著(症例報告除く)
|
Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan. 2017/01
|
|
56.
|
症例報告
|
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases 2016/12
|
|
57.
|
原著(症例報告除く)
|
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA? 2016/11
|
|
58.
|
症例報告
|
食道空腸吻合に困難と判断し化学療法を先行した胃癌・悪性リンパ腫の重複癌症例 2016/11
|
|
59.
|
原著(症例報告除く)
|
再発・難治性B細胞リンパ腫患者に対する90Y-標識イブリツモマブ・チウキセタン療法の単施設における後方視的検討 2016/10
|
|
60.
|
症例報告
|
Bortezomibにより早期改善を認めたIgD骨髄腫関連高アンモニア脳症 2016/07
|
|
61.
|
症例報告
|
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia 2016/07
|
|
62.
|
症例報告
|
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma 2016/06
|
|
63.
|
総説
|
見逃すと大変なことになる血液疾患 2016/06
|
|
64.
|
総説
|
薬物と止血凝固異常(第2回) 免疫調節薬と止血凝固異常 2016/03
|
|
65.
|
原著(症例報告除く)
|
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report 2016/02
|
|
66.
|
原著(症例報告除く)
|
Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation 2016/01
|
|
67.
|
症例報告
|
急性リンパ性白血病に発症した中枢神経原発移植後リンパ増殖性疾患 2015/08
|
|
68.
|
総説
|
造血幹細胞移植とサイト研究 2015/04
|
|
69.
|
原著(症例報告除く)
|
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma 2015/01
|
|
70.
|
その他
|
Successful prevention of tumor lysis syndrome (TLS) and disseminated intravascular coagulation (DIC) with Rasburicase and recombinant thrmbomodulin (rTM) invhematological malignancies. 2014/12
|
|
71.
|
症例報告
|
治療抵抗性のITPに対し悪性リンパ腫の関与が疑われた一症例 2014/12
|
|
72.
|
症例報告
|
HLA不適合によるNAITPと考えられたWiskott-Aldrich症候群の一例 2014/11
|
|
73.
|
その他
|
Immunotherapeutic effects of Ninjin-youei-to on patients with multiple myeloma. 2014/11
|
|
74.
|
原著(症例報告除く)
|
全自動輸血検査装置ERYTRAを用いた輸血検査の基礎的検討 2014/08
|
|
75.
|
その他
|
The preventive effects of recombinant thrombomodulin on transplantation-associated coagulopathy after allogeneic hematopoietic stem cell transplantation. 2014/07
|
|
76.
|
症例報告
|
同種骨髄移植後に非血縁者ドナー由来と考えられるHLA抗体が産生された症例 2014/06
|
|
77.
|
その他
|
移植非適応MM標準治療を考える。診療ガイドラインをふまえて(座談会) 2014/05
|
|
78.
|
原著(症例報告除く)
|
Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents 2014/04
|
|
79.
|
その他
|
Significance of anti-GPIIb/IIIa antibody in efficacy of eltrombopag for patients with immune thrombocytopenia 2014/04
|
|
80.
|
原著(症例報告除く)
|
Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study. 2013/09
|
|
81.
|
総説
|
造血器疾患と止血凝固(第2回) 慢性骨髄性白血病と血管内皮障害 2013/06
|
|
82.
|
その他
|
学会見聞録「第74回日本血液学会学術集会」 2013/04
|
|
83.
|
原著(症例報告除く)
|
Recombinant thrombomodulin reduces the elevation of PAI-1 after allogeneic hematopoietic stem cell transplantation. 2013/02
|
|
84.
|
症例報告
|
血球貪食症候群を繰り返しDICを発症したNK/Tリンパ腫の一例 2013/02
|
|
85.
|
その他
|
骨髄異形成症候群と赤血球輸血 2013/02
|
|
86.
|
その他
|
TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP. 2012/09
|
|
87.
|
その他
|
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation. 2012/07
|
|
88.
|
その他
|
Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation? 2011/06
|
|
89.
|
その他
|
The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy. 2011/03
|
|
90.
|
その他
|
Dynamic role of cell-derived microparticles in hematopoietic stem cell transplantion 2011
|
|
91.
|
原著(症例報告除く)
|
特発性血小板減少性紫斑病におけるヘリコバクター･ピロリ菌除菌療法とHLAクラスIIアリルとの関係 2007/08
|
|
92.
|
症例報告
|
A case of hemophagocytic lymphohistiocytosis after the primary Epstein-Barr virus infection 2007/07
|
|
93.
|
症例報告
|
ALK陽性,CD30陰性のびまん性大細胞型B細胞性リンパ腫 2005
|
|
94.
|
その他
|
Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-derived microparticles in TMA/TTP. Bone Marrow Transplant. 2005
|
|
95.
|
原著(症例報告除く)
|
高齢者aggressive 非ホジキンリンパ腫に対するVNCOP-B療法（etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin）有効性と安全性に関する検討- 最終報告． 2005
|
|
96.
|
その他
|
目でみるトレーニング． 2005
|
|
97.
|
総説
|
【ITP(特発性血小板減少性紫斑病) 最近の進歩】 難治性ITPの取り扱いと新たな治療戦略(移植を含む) 2004
|
|
98.
|
原著(症例報告除く)
|
イマチニブ投与中にtrisomy8が出現したCML 2004
|
|
99.
|
原著(症例報告除く)
|
多発性骨折にて発症した成人T細胞白血病リンパ腫 2004
|
|
100.
|
症例報告
|
早期に脳出血を発症した顕微鏡的多発血管炎の1例 2003/02
|
|
101.
|
症例報告
|
As203が著効した再発難治性急性前骨髄性白血病． 2000
|
|
102.
|
症例報告
|
播種性Fusarium感染症を合併した急性骨髄性白血病の１例． 2000
|
|
103.
|
原著(症例報告除く)
|
Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles 1996
|
|
104.
|
総説
|
主要熱帯感染症の予防. 1994
|
|
105.
|
症例報告
|
Bloom's Syndrome complicated by myelodysplatic syndrome and multiple neoplasia. 1993
|
|
106.
|
原著(症例報告除く)
|
Immunoglobulin prophylaxis against Human T Cell Lymphotropic Virus Type II in rabbits. 1993
|
|
107.
|
原著(症例報告除く)
|
Prophylaxis against a Melanesian variant of Human T-Lymphotropic Virus Type I (HTLV-I) in rabbits using HTLV-I immunoglobulin from asymptomatically infected Japanese carriers. 1993
|
|
108.
|
その他
|
Excretion of HTLV-I in saliva. 1992
|
|
109.
|
原著(症例報告除く)
|
IgD myeloma presenting as a testicular tumor: establishment and characterization of an IgD-secreting myeloma cell line. 1992
|
|
110.
|
症例報告
|
成人に発症したSalmonella oranienburg敗血症, 髄膜炎の１例. 1992
|
|
111.
|
原著(症例報告除く)
|
Immunoglobulin prophylaxis against milk borne transmission of human T cell leukemia virus type I in rabbit. 1991
|
|
112.
|
その他
|
Isolation of HTLV-I from muscle of a patient with polymyositis 1991
|
|
113.
|
原著(症例報告除く)
|
Isochromosome 11q in acute monoblastic leukemia (M5a). 1990
|
|
5件表示
|
|
全件表示(113件)
|
